WHO Policy Perspectives on Medicines 9

First Page		Document Content
Date: 2005-01-24 10:02:48 Health Medicine Pharmacy Drug safety Clinical research Pharmacovigilance Uppsala Monitoring Centre Adverse effect Essential medicines Pharmaceutical sciences Pharmacology Pharmaceuticals policy		WHO Policy Perspectives on Medicines 9 Add to Reading List Source URL: whqlibdoc.who.int Download Document from Source Website File Size: 117,69 KB Share Document on Facebook

	PHARMACOVIGILANCE GUIDE FOR ADVERSE DRUG REACTION MONITORING AND CAUSALITY ASSESSMENT, 2015 Post marketing Control Division, DocID: 1p9e5 - View Document
	Pitfalls of disproportionality analysis PROTECT Symposium tutorial Niklas Norén, PhD Uppsala Monitoring Centre Feb 18, 2015 DocID: 1dNrj - View Document
	Signal detection in electronic medical records PROTECT Symposium Niklas Norén, PhD Uppsala Monitoring Centre DocID: 1bFjc - View Document
	Use of ontologies in signal detection SPC section 4.8 coding subpackage • Map each textual description of an adverse drug reaction in section 4.8 of the SPC for centrally DocID: 1aT2N - View Document
	184 Asian Journal of Pharmaceutical and Clinical Research ADVERSE DRUG REACTIONS REPORTING: ATTITUDES AND PERCEPTIONS OF MEDICAL PRACTITIONERS * DocID: 19Htw - View Document